These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 22246736

  • 1. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.
    Liu D, Xu H, Tian B, Yuan K, Pan H, Ma S, Yang X, Pan W.
    AAPS PharmSciTech; 2012 Mar; 13(1):295-304. PubMed ID: 22246736
    [Abstract] [Full Text] [Related]

  • 2. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, Cui F.
    Eur J Pharm Sci; 2010 Jul 11; 40(4):325-34. PubMed ID: 20417274
    [Abstract] [Full Text] [Related]

  • 3. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.
    Rahim H, Sadiq A, Khan S, Amin F, Ullah R, Shahat AA, Mahmood HM.
    Int J Nanomedicine; 2019 Jul 11; 14():6287-6296. PubMed ID: 31496686
    [Abstract] [Full Text] [Related]

  • 4. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation.
    Geng T, Banerjee P, Lu Z, Zoghbi A, Li T, Wang B.
    Eur J Pharm Sci; 2017 Nov 15; 109():200-208. PubMed ID: 28811130
    [Abstract] [Full Text] [Related]

  • 5. Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation.
    Liu D, Pan H, He F, Wang X, Li J, Yang X, Pan W.
    Int J Nanomedicine; 2015 Nov 15; 10():6425-34. PubMed ID: 26508852
    [Abstract] [Full Text] [Related]

  • 6. Preparation of azithromycin nanosuspensions by reactive precipitation method.
    Hou CD, Wang JX, Le Y, Zou HK, Zhao H.
    Drug Dev Ind Pharm; 2012 Jul 15; 38(7):848-54. PubMed ID: 22092042
    [Abstract] [Full Text] [Related]

  • 7. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X, Zhang T, Lan Y, Wu B, Shi Z.
    AAPS PharmSciTech; 2016 Apr 15; 17(2):400-8. PubMed ID: 26187778
    [Abstract] [Full Text] [Related]

  • 8. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
    Yuan H, Li X, Zhang C, Pan W, Liang Y, Chen Y, Chen W, Liu L, Wang X.
    Drug Deliv; 2016 Oct 15; 23(8):2772-2779. PubMed ID: 26292058
    [Abstract] [Full Text] [Related]

  • 9. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol.
    Patil SS, Roy K, Choudhary B, Mahadik KR.
    Drug Dev Ind Pharm; 2016 Aug 15; 42(8):1300-7. PubMed ID: 26651381
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y, Sun C, Hao Y, Jiang T, Zheng L, Wang S.
    J Pharm Pharm Sci; 2010 Aug 15; 13(4):589-606. PubMed ID: 21486533
    [Abstract] [Full Text] [Related]

  • 11. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
    Wang Y, Han X, Wang J, Wang Y.
    Int J Pharm; 2016 May 30; 505(1-2):35-41. PubMed ID: 27034003
    [Abstract] [Full Text] [Related]

  • 12. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X, Sun C, Jiang T, Zheng L, Wang T, Wang S.
    J Pharm Pharm Sci; 2011 May 30; 14(2):196-214. PubMed ID: 21733409
    [Abstract] [Full Text] [Related]

  • 13. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
    Gera S, Talluri S, Rangaraj N, Sampathi S.
    AAPS PharmSciTech; 2017 Nov 30; 18(8):3151-3162. PubMed ID: 28534300
    [Abstract] [Full Text] [Related]

  • 14. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY, Shah DA, Dave RH.
    Int J Pharm; 2019 Mar 25; 559():348-359. PubMed ID: 30721724
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y, Wu W, Zhao X, Li Y, Wang W, Zhong C, Zhang Y, Zhao X.
    Int J Pharm; 2014 Aug 25; 471(1-2):366-76. PubMed ID: 24882039
    [Abstract] [Full Text] [Related]

  • 16. Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nano-suspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution.
    Xie Y, Chen Z, Su R, Li Y, Qi J, Wu W, Lu Y.
    Curr Drug Deliv; 2017 Aug 25; 14(4):483-491. PubMed ID: 27593183
    [Abstract] [Full Text] [Related]

  • 17. Nanoprecipitation with sonication for enhancement of oral bioavailability of furosemide.
    Sahu BP, Das MK.
    Acta Pol Pharm; 2014 Aug 25; 71(1):129-37. PubMed ID: 24779201
    [Abstract] [Full Text] [Related]

  • 18. [Preparation of valsartan nanosuspensions and its in vitro dissolution].
    Li F, Song SS, Liu Y, Guo YX, Pan WS, Yang XG.
    Yao Xue Xue Bao; 2013 Aug 25; 48(8):1312-8. PubMed ID: 24187842
    [Abstract] [Full Text] [Related]

  • 19. Novel carvedilol paediatric nanomicelle formulation: in-vitro characterization and in-vivo evaluation.
    Wegmann M, Parola L, Bertera FM, Taira CA, Cagel M, Buontempo F, Bernabeu E, Höcht C, Chiappetta DA, Moretton MA.
    J Pharm Pharmacol; 2017 May 25; 69(5):544-553. PubMed ID: 27431770
    [Abstract] [Full Text] [Related]

  • 20. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
    Pu X, Sun J, Wang Y, Wang Y, Liu X, Zhang P, Tang X, Pan W, Han J, He Z.
    Int J Pharm; 2009 Sep 08; 379(1):167-73. PubMed ID: 19505545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.